AfoliOpen Afoli →

Brivaracetam

Brivaracetam is an active ingredient of the class «anticonvulsant agent».

Open in Afoli Medicines →

Chemical compound

Informational only — not medical advice. Ask a doctor or pharmacist; never change a dose on your own.

What it is used for

BRIVIACT is indicated for the treatment of partial-onset seizures in patients 1 month of age and older. BRIVIACT is indicated for the treatment of partial-onset seizures in patients 1 month of age and older.

US label

Briviact is indicated as adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in adult and adolescent patients from 16 years of age with epilepsy.

EMA

How it works

Class: anticonvulsant agent

Common side effects

The following serious adverse reactions are described elsewhere in labeling: Suicidal Behavior and Ideation Neurological Adverse Reactions Psychiatric Adverse Reactions Hypersensitivity: Bronchospasm and Angioedema Serious Dermatologic Reactions Withdrawal of Antiepileptic Drugs Adults: Most common adverse reactions…

US label

Who should not take it

Hypersensitivity to brivaracetam or any of the inactive ingredients in BRIVIACT (bronchospasm and angioedema have occurred). Hypersensitivity to brivaracetam or any of the inactive ingredients in BRIVIACT.

US label

Pregnancy and breastfeeding

Exposure Registry There is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to antiepileptic drugs (AEDs), such as BRIVIACT, during pregnancy.

Excerpts from the US prescribing label (public domain), copied without changes.

Interactions

Recorded interactions from open sources (Wikidata, US labels). The list is not complete — ask a pharmacist.

Brand names

United States

Briviact

European Union

Briviact (in Italy: Nubriveo)

Canada

Apo-Brivaracetam · Auro-Brivaracetam · Brivlera · Mint-Brivaracetam · Zds-Brivaracetam

Approval status

US Food and Drug Administration
prescription · since 2016
European Medicines Agency
authorised · since 2016
Health Canada
prescription · marketed
First approval anywhere
2016

Codes

ATC
N03AX23
RxNorm CUI
1739745
ChEMBL
CHEMBL607400
PubChem CID
9837243
UNII
U863JGG2IA
Wikidata
Q408099

Frequently asked questions

What is Brivaracetam used for?

Brivaracetam is used for: Epilepsy and Seizure.

What kind of medicine is Brivaracetam?

Brivaracetam is an active ingredient of the class «anticonvulsant agent».

What are the brand names of Brivaracetam?

Brand names of Brivaracetam include Briviact, Briviact (in Italy: Nubriveo), Apo-Brivaracetam, Auro-Brivaracetam, Brivlera, Mint-Brivaracetam, and Zds-Brivaracetam.

Medicines in the same class

Sources and licences

Updated November 15, 2026